期刊文献+

cN0甲状腺乳头状癌中央区淋巴结阳性与侧区淋巴结转移的关系 被引量:3

The relationship between the central cervical lymph node metastasis and the lateral cervical lymph node metastasis in cN0 papillary thyroid cancer
原文传递
导出
摘要 目的 探讨甲状腺乳头状癌中央区淋巴结阳性与侧区淋巴结的关系.方法 回顾性分析首都医科大学附属北京友谊医院2009年1月至2012年12月行预防性颈淋巴结清扫的50例甲状腺乳头状癌资料.女36例,男14例.结果 根据患者中央区淋巴结阳性数目分为3组:中央区淋巴结转移数=1(A组,n =21),中央区淋巴结转移数=2(B组,n=11),中央区淋巴结转移数≥3(C组,n=18),各组相应侧区淋巴结受累的风险分别为47.5%、81.8%、88.9% (P =0.012).单因素分析提示T3~4及中央区淋巴结阳性数≥2枚是侧区淋巴结转移的危险因素.多因素分析提示中央区淋巴结阳性数≥2枚是独立的危险因素(OR 4.67,95% CI1 ~22),阳性预测值为86.2%.结论 T3~4或中央区淋巴结阳性数量≥2枚是PTC侧区淋巴结转移的高危因素,可考虑行预防性颈部淋巴结清扫. Objective To analyze the relationship between central cervical lymph node metastasis and the lateral cervical lymph node metastasis in cN0 papillary thyroid cancer.Methods We retrogradely analyze 50 cases of papillary thyroid cancer who had prophylactic modified neck dissection in recent three years.There were 36 females and 14 males patients.Patients were divided into three groups according to the number of positive CCLN:groupA=1(n=21); B=2(n=11) andC≥3(n=18).Results The risk of lateral compartment lymph nodes involvement increased in parallel with the number of positive CCLN(47.5% vs.81.8% vs.88.9% in groups A,B and C,respectively; P =0.012).Univariate analysis revealed the number of CCLN ≥ 2 (P =0.04),T3-4 (P =0.049) were risk factors for the metastasis in the lateral neck.However,multi-variate analysis implied only the C CLN ≥ 2 was the independent factor(OR 4.67,95 % CI 1 ~22),with a positive predictive value 86.2%.Conclusion T3-4 and positive CCLN ≥ 2 are risk factors for lateral compartment involvement in cN0 PTC,prophylactic modified neck dissection can be considered.
出处 《中华内分泌外科杂志》 CAS 2014年第3期223-226,共4页 Chinese Journal of Endocrine Surgery
关键词 甲状腺乳头状癌 中央区淋巴结 侧区淋巴结 转移 Papillary thyroid cancer Central cervical lymph node Lateral cervical lymph node Metastasis
  • 相关文献

参考文献23

  • 1Cooper DS, Doherty GM, Haugen BR. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[ J]. Thyroid ,2006,16 (2) : 109-142.
  • 2Kelemen PR, Van Herle A J, Giuliano AE. Sentinel lymphadenecto- my in thyroid malignant neoplasms[J]. Arch Surg,1998,133(3) : 288 -292.
  • 3Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms [ J]. World J Surg,2000,24( 11 ) :1396-1401.
  • 4Chung YS, Kim JY, Bae JS, et al. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection [ J ]. Thyroid,2009,19 ( 3 ) : 241-246.
  • 5Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preopera- tive ultrasonography in the surgical management of patients with thyroid cancer [ J ]. Surgery,2003,134 (6) :946-954.
  • 6Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid micro-carcinomas: frequency, pattern of oc- currence and recurrence, and optimal strategy for neck dissection [J]. Ann Surg,2003,237(3) :399-407.
  • 7Japanese Society of Thyroid Surgery/Japanese Society of Endo- crine Surgeons. Guidelines for management of thyroid tumor[ M ]. Tokyo: Kanehara; 2010.
  • 8Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thy- reid nodules and differentiated thyroid cancer[ J ]. Thyroid,2009, 19( 11 ) :1167-1214.
  • 9Shindo M, Wu JC, Park EE, et al. The importance of central compartment elective lymph node excision in the staging and treat- ment of papillary thyroid cancer[J]. Arch Otolaryngol Head Neck Surg,2006,132(6) :650-654.
  • 10White ML, Gauger PG, Doherty GM. Central lymph node dissec- tion in differentiated thyroid cancer [ J ]. World J Surg, 2007,31 (5) :895-904.

二级参考文献66

  • 1施秉银.美国“甲状腺结节和分化性甲状腺癌诊断治疗指南”解读(Ⅰ)[J].中华内分泌代谢杂志,2006,22(2):194-194. 被引量:27
  • 2闫卫,张园.局部晚期分化型甲状腺癌的外科治疗[J].南京医科大学学报(自然科学版),2006,26(11):1120-1121. 被引量:7
  • 3李树玲.甲状腺乳头状癌的外科治疗[J].国外医学:肿瘤学分册,1984,(4):193-193.
  • 4Shattuck TM, Westra WH, Ladenson PW, et al. Independent clonal origins of distinct tumor foci in muhifocal papillary thyroid carcinoma. N Engl J Med,2005,352 : 2406-2412.
  • 5Park SY, Park YJ, Lee Y J, et al. Analysis of differential BRAF (V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor loci. Cancer, 2006,107 : 1831-1838.
  • 6Kim ES, Kim TY, Koh JM, et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) , 2004,61 : 145-148.
  • 7British Thyroid Association. Guidelines for the Management of Thyroid Cancer in Adults. London: Royal College of Physicians, 2002:200.
  • 8Robbins KT. Pocket guide to neck dissection classification and TNM staging of head and neck cancer [M]. Alexandria.American Academy of Otolaryngology Head and Neck Surgery Foundation, Inc, Va22314, USA 1991:9-20.
  • 9Hay ID. Papillary thyroid carcinoma [,J]. Endocrinol Metab Clin North Am, 1990,19(3):545-576.
  • 10Rao RS, Parikh DM, Mistry RC, et al. Evidence-based protocols for the management of well-differrentiated carcinomas of the thyroid[J]. Asian J Surg, 2002,25 (4) :319-324.

共引文献110

同被引文献44

  • 1Chen AY, Jemal A, Ward EM. Increasing incidence of differenti- ated thyroid cancer in the United States, 1988-2005[J].Cancer, 2009,115(16) : 3801-3807.
  • 2Wang Z, Dong ZY, Chen JQ, et al. Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis [J].Ann Surg Oncol, 2012,19(5) : 1541 - 1550.
  • 3Markovina S, Grigsby PW, Schwarz JK, ct al. Treatment ap- proach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence [J].Thyroid, 2014, 24(7): 1121-1126.
  • 4Podnos YD, Smith D, Wagman LD, et al. The implication of lymph node metastasis on survival in patients with well-differen- tiated thyroid cancer [ J ].Am Surg, 2005,71 (9) : 731-734.
  • 5Zaydfudim V, Feurer ID, Griffin MR, et al. The impact of lymph node involvement on survival in patients with papillary and fol- licular thyroid carcinoma[J].Surgery,2008,144(6): 1070-1078.
  • 6Anand SM, Gologan O, Roehon L, et al. The role of sentinel lymph node biopsy in differentiated thyroid carcinoma [J].Arch Otolaryngol Head Neck Surg,2009,135(12): 1199-1204.
  • 7Iyer NG, Kumar A, Nixon IJ, et al. Incidence and significance of Delphian node metastasis in papillary thyroid cancer [J].Ann Surg, 2011,253(5) : 988-991.
  • 8Bonnet S, Hard D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm : implica- tions for radioiodine treatment [J]. J Clin Endocrinol Metab, 2009,4(94) : 1162-1167.
  • 9Roh JL, Kim JM, Park CI. Central lymph node metastasis of uni- lateral papillary thyroid carcinoma: patterns and factors predic- tive of nodal metastasis, morbidity, and recurrence [J ]. Ann Surg Oncol, 2011,18(8) : 2245-2250.
  • 10Hao RT, Chen J, Zhao LH, et al. Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma [ J ] .EJSO,2012,38(8) : 718-724.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部